WallStSmart
CDTX

Cidara Therapeutics Inc

NASDAQ: CDTX · HEALTHCARE · BIOTECHNOLOGY

$221.38
+0.00% today

Updated 2026-01-07

Market cap
$6.96B
P/E ratio
P/S ratio
4,540.70x
EPS (TTM)
$-11.20
Dividend yield
52W range
$15 – $221
Volume
1.5M

Cidara Therapeutics Inc (CDTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+9.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-26.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.5%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+6.9%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-06$-3.10-11.9%$97.64$104.39+6.9%
2025-08-07$-1.65+45.7%$61.99$62.00+0.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$-2.77$-3.10-11.9%
2025-06-30$-3.04$-1.65+45.7%
2025-03-31$-3.47$-1.66+52.2%
2024-12-31$-3.67$-5.38-46.5%
2024-09-30$-4.25$-2.45+42.4%
2024-06-30$-3.22$-19.99-520.8%$302000.00-94.1%
2024-03-31$-0.20$-2.28-1040.0%$973000.00-96.3%
2023-12-31$-0.10$-0.04+60.0%$17.58M+72.1%
2023-09-30$-0.16$-0.09+43.8%$9.22M
2023-06-30$-0.13$-0.14-7.7%$5.09M
2023-03-31$-0.04$0.03+175.0%$26.11M
2022-12-31$-0.17$-0.19-11.8%$10.22M

Frequently asked questions

Has Cidara Therapeutics Inc beaten earnings estimates?
Cidara Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +9.9% over the last 4 quarters.
How does CDTX stock react to earnings?
CDTX stock has moved an average of +3.5% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.